INFINITY PHARMACEUTICALS, INC. 4
4 · INFINITY PHARMACEUTICALS, INC. · Filed May 1, 2015
Insider Transaction Report
Form 4
Palombella Vito J.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2015-04-30−4,737→ 0 totalExercise: $2.04From: 2005-05-10Exp: 2015-05-10→ Common Stock (4,737 underlying) - Exercise/Conversion
Common Stock
2015-04-30$2.04/sh+4,737$9,663→ 5,605 total
Holdings
- 6,741.146(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]This stock option was granted under the issuer's Pre-Merger Stock Incentive Plan, which permits the early exercise of unvested stock options in exchange for shares of restricted stock that are subject to a right of repurchase by the issuer that lapses in accordance with the vesting schedule of the original option. This option is fully vested.